Fungi in the gingival sulcus: frequency and speciation in HIV+ and HIV- heterosexual patients. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Fungi in the gingival sulcus: frequency and speciation in HIV+ and HIV- heterosexual patients.

Abstr Gen Meet Am Soc Microbiol. 1994;94:600 (abstract no. F-70). Unique Identifier : AIDSLINE ASM94/94313116
Quart A; Gialanella P; McEachrane S; Reich D; AIDS Initiative, North Central Bronx Hospital, N.Y.

Abstract: Oral candidiasis is one of the earliest and most common signs of HIV infection, suggesting that the oral cavity may be a reservoir of yeast colonization in both immunocompetent and immunosuppressed individuals. In this study 1168 samples taken from the gingival sulci of 237 Bronx methadone clinic patients were assayed for yeasts. Of these patients, 143 were male, 94 female. 142 were HIV-, 95 were HIV+. TABULAR DATA, SEE ABSTRACT VOLUME. C. albicans was the most frequently cultured organism in all groups, with C. tropicalis second. While virtually all samples from HIV+ patients grew out fungal organisms, 72.5% of HIV- patients also grew out fungal organisms. Many patients in both groups showed two or more species. Detailed analysis will be correlated with the possible role of the gingival sulcus as a fungal storage area in both immunocompetent and immunosuppressed individuals.
Keywords: Animal Candida/*ISOLATION & PURIF Candida albicans/ISOLATION & PURIF Comparative Study Female Gingiva/*MICROBIOLOGY/*PARASITOLOGY Human *HIV Seronegativity HIV Seropositivity/*MICROBIOLOGY Male *Sex Behavior Toxoplasma/*ISOLATION & PURIF ABSTRACTKWDanimalcandida/KWDisolation&purifcandidaalbicans/isolation&purifcomparativestudyfemalegingiva/KWDmicrobiology/KWDparasitologyhumanKWDhivseronegativityhivseropositivity/KWDmicrobiologymaleKWDsexbehaviortoxoplasma/KWDisolation&purifabstract
941030
M94A0838

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .